SLC2A3 and neoplasm: Moreover, GLUT3-CAR T-cells demonstrated superior anti-tumor activity compared to unarmored CAR T-cells in both xenogeneic and syngeneic mouse models of solid tumors, including pancreatic, esophageal, and lung cancer (141).